Lyon-based Brenus Pharma secures €22.2M to advance cancer vaccine trials: Here's how
Lyon, France-based Brenus Pharma, a biotech company specialising in developing cancer vaccines, announced on Wednesday that it has secured €22.2M in a Series A funding round.